145 related articles for article (PubMed ID: 38007948)
1. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.
Jia K; Kundrot S; Palchuk MB; Warnick J; Haapala K; Kaplan ID; Rinard M; Appelbaum L
EBioMedicine; 2023 Dec; 98():104888. PubMed ID: 38007948
[TBL] [Abstract][Full Text] [Related]
2. Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer.
Chen W; Zhou Y; Xie F; Butler RK; Jeon CY; Luong TQ; Zhou B; Lin YC; Lustigova E; Pisegna JR; Kim S; Wu BU
Am J Gastroenterol; 2023 Jan; 118(1):157-167. PubMed ID: 36227806
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study.
Appelbaum L; Cambronero JP; Stevens JP; Horng S; Pollick K; Silva G; Haneuse S; Piatkowski G; Benhaga N; Duey S; Stevenson MA; Mamon H; Kaplan ID; Rinard MC
Eur J Cancer; 2021 Jan; 143():19-30. PubMed ID: 33278770
[TBL] [Abstract][Full Text] [Related]
4. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
Nakamura K; Zhu Z; Roy S; Jun E; Han H; Munoz RM; Nishiwada S; Sharma G; Cridebring D; Zenhausern F; Kim S; Roe DJ; Darabi S; Han IW; Evans DB; Yamada S; Demeure MJ; Becerra C; Celinski SA; Borazanci E; Tsai S; Kodera Y; Park JO; Bolton JS; Wang X; Kim SC; Von Hoff D; Goel A
Gastroenterology; 2022 Nov; 163(5):1252-1266.e2. PubMed ID: 35850192
[TBL] [Abstract][Full Text] [Related]
5. Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical Diagnosis.
Mukherjee S; Patra A; Khasawneh H; Korfiatis P; Rajamohan N; Suman G; Majumder S; Panda A; Johnson MP; Larson NB; Wright DE; Kline TL; Fletcher JG; Chari ST; Goenka AH
Gastroenterology; 2022 Nov; 163(5):1435-1446.e3. PubMed ID: 35788343
[TBL] [Abstract][Full Text] [Related]
6. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.
Balasenthil S; Huang Y; Liu S; Marsh T; Chen J; Stass SA; KuKuruga D; Brand R; Chen N; Frazier ML; Jack Lee J; Srivastava S; Sen S; McNeill Killary A
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376184
[TBL] [Abstract][Full Text] [Related]
7. Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma.
Firpo MA; Boucher KM; Bleicher J; Khanderao GD; Rosati A; Poruk KE; Kamal S; Marzullo L; De Marco M; Falco A; Genovese A; Adler JM; De Laurenzi V; Adler DG; Affolter KE; Garrido-Laguna I; Scaife CL; Turco MC; Mulvihill SJ
JCO Clin Cancer Inform; 2023 Mar; 7():e2200160. PubMed ID: 36913644
[TBL] [Abstract][Full Text] [Related]
8. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
Dittmar RL; Liu S; Tai MC; Rajapakshe K; Huang Y; Longton G; DeCapite C; Hurd MW; Paris PL; Kirkwood KS; Coarfa C; Maitra A; Brand RE; Killary AM; Sen S
Cancer Prev Res (Phila); 2021 Jul; 14(7):729-740. PubMed ID: 33893071
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
[TBL] [Abstract][Full Text] [Related]
10. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
[TBL] [Abstract][Full Text] [Related]
11. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
12. Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data.
Baecker A; Kim S; Risch HA; Nuckols TK; Wu BU; Hendifar AE; Pandol SJ; Pisegna JR; Jeon CY
PLoS One; 2019; 14(6):e0218580. PubMed ID: 31237889
[TBL] [Abstract][Full Text] [Related]
13. Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).
Kang JS; Mok L; Heo JS; Han IW; Shin SH; Yoon YS; Han HS; Hwang DW; Lee JH; Lee WJ; Park SJ; Park JS; Kim Y; Lee H; Yu YD; Yang JD; Lee SE; Park IY; Jeong CY; Roh Y; Kim SR; Moon JI; Lee SK; Kim HJ; Lee S; Kim H; Kwon W; Lim CS; Jang JY; Park T
Gut Liver; 2021 Nov; 15(6):912-921. PubMed ID: 33941710
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Tumor-Infiltrating CD20
Li Q; Yu J; Zhang H; Meng Y; Liu YF; Jiang H; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Feng X; Lu J; Shao C; Bian Y
Acad Radiol; 2022 Sep; 29(9):e167-e177. PubMed ID: 34922828
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Pancreatic Cancer Based on Imaging Features in Patients With Duct Abnormalities.
Chen W; Butler RK; Zhou Y; Parker RA; Jeon CY; Wu BU
Pancreas; 2020 Mar; 49(3):413-419. PubMed ID: 32132511
[TBL] [Abstract][Full Text] [Related]
16. Multicenter study of early pancreatic cancer in Japan.
Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
[TBL] [Abstract][Full Text] [Related]
17. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract][Full Text] [Related]
18. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma.
Meng Y; Zhang H; Li Q; Xing P; Liu F; Cao K; Fang X; Li J; Yu J; Feng X; Ma C; Wang L; Jiang H; Lu J; Bian Y; Shao C
J Magn Reson Imaging; 2021 Nov; 54(5):1432-1443. PubMed ID: 33890347
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
